Functions and mechanisms of circular RNAs in cancer radiotherapy and chemotherapy resistance

被引:0
|
作者
Chaochu Cui
Jianbo Yang
Xiao Li
Dongling Liu
Liwu Fu
Xianwei Wang
机构
[1] Xinxiang Medical University,Henan Key Laboratory of Medical Tissue Regeneration, College of Basic Medical Sciences
[2] Xinxiang Medical University,School of Laboratory Medicine
[3] Sun Yat-sen University Cancer Center,State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine
来源
关键词
circRNAs; Cancer therapy; Sensitivity; Radioresistance; Chemoresistance; Multidrug resistance;
D O I
暂无
中图分类号
学科分类号
摘要
Circular RNAs (circRNAs), one type of non-coding RNA, were initially misinterpreted as nonfunctional products of pre-mRNA mis-splicing. Currently, circRNAs have been proven to manipulate the functions of diverse molecules, including non-coding RNAs, mRNAs, DNAs and proteins, to regulate cell activities in physiology and pathology. Accumulating evidence indicates that circRNAs play critical roles in tumor genesis, development, and sensitivity to radiation and chemotherapy. Radiotherapy and chemotherapy are two primary types of intervention for most cancers, but their therapeutic efficacies are usually retarded by intrinsic and acquired resistance. Thus, it is urgent to develop new strategies to improve therapeutic responses. To achieve this, clarification of the underlying mechanisms affecting therapeutic responses in cancer is needed. This review summarizes recent progress and mechanisms of circRNAs in cancer resistance to radiation and chemotherapy, and it discusses the limitations of available knowledge and potential future directions.
引用
收藏
相关论文
共 50 条
  • [1] Functions and mechanisms of circular RNAs in cancer radiotherapy and chemotherapy resistance
    Cui, Chaochu
    Yang, Jianbo
    Li, Xiao
    Liu, Dongling
    Fu, Liwu
    Wang, Xianwei
    MOLECULAR CANCER, 2020, 19 (01)
  • [2] Circular RNAs in gynecologic cancers: mechanisms and implications for chemotherapy resistance
    Qin, Meiying
    Zhang, Chunmei
    Li, Yang
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [3] Exosomal circular RNAs: A chief culprit in cancer chemotherapy resistance
    Guo, Xu
    Gao, Congying
    Yang, Dong-Hua
    Li, Shenglong
    DRUG RESISTANCE UPDATES, 2023, 67
  • [4] Circular RNAs: characteristics, biogenesis, mechanisms and functions in liver cancer
    Hao Shen
    Boqiang Liu
    Junjie Xu
    Bin Zhang
    Yifan Wang
    Liang Shi
    Xiujun Cai
    Journal of Hematology & Oncology, 14
  • [5] Circular RNAs: characteristics, biogenesis, mechanisms and functions in liver cancer
    Shen, Hao
    Liu, Boqiang
    Xu, Junjie
    Zhang, Bin
    Wang, Yifan
    Shi, Liang
    Cai, Xiujun
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 14 (01)
  • [6] The Functions and Mechanisms of Translatable Circular RNAs
    Liu, Chang
    Wu, Xinying
    Gokulnath, Priyanka
    Li, Guoping
    Xiao, Junjie
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2023, 384 (01): : 52 - 60
  • [7] Circular RNAs in chemotherapy resistance of lung cancer and their potential therapeutic application
    Yi, Qian
    Feng, Jianguo
    Liao, Yi
    Sun, Weichao
    IUBMB LIFE, 2023, 75 (03) : 225 - 237
  • [8] The role of circular RNAs in triple negative breast cancer and chemotherapy resistance
    Wang, Xiyin
    Emch, Michael J.
    Tang, Xiaojia
    Yu, Jia
    Kalari, Krishna R.
    Wang, Liewei
    Goetz, Matthew P.
    Hawse, John R.
    CANCER RESEARCH, 2023, 83 (07)
  • [9] Circular RNAs: characteristics, functions, mechanisms, and potential applications in thyroid cancer
    Mengmeng Wu
    Haibin Yuan
    Weiwei Zou
    Shujian Xu
    Song Liu
    Qiang Gao
    Qingqun Guo
    Yong Han
    Xingguo An
    Clinical and Translational Oncology, 2024, 26 : 808 - 824
  • [10] Circular RNAs: characteristics, functions, mechanisms, and potential applications in thyroid cancer
    Wu, Mengmeng
    Yuan, Haibin
    Zou, Weiwei
    Xu, Shujian
    Liu, Song
    Gao, Qiang
    Guo, Qingqun
    Han, Yong
    An, Xingguo
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (04): : 808 - 824